Breaking News

Urology Department

  • Vision
  • Mission
  • Head of the Department
  • Staff Members
  • Research field
  • Achievements
  • Techniques
  • Structure
  • Training
  • Services Scope
  • Projects
  • Publications
To be a center of excellence in the Urology field
 To provide medical care regarding “diagnosis and treatment” for all urological problems according to the international up-to-date 1st class standards and at the same time, participate in applied clinical research.

Prof. Hussien Badawy




Former heads

    • Dr. Hazem Elturk
    • Dr. Mohamed Mohey El-Din Wishahi
    • Dr. Ahmed Aziz Abd El-Aty
    • Dr. Essam El-Din Mahmoud Riad
    • Dr. Ahmed Gamal El-Baz
    • Dr. Mamdouh Amin Roshdy
    • Dr. Tarek Ramzy El-Leithy
    • Dr. Samir El-Sayed El-Ghobashi

Staff Members

  1.  Urologic oncology and reconstruction
  2.  Obstructive Uropathy (Stones, strictures, infravesical obstruction including prostate)
  3.  Stone diseases
  4.  Urinary tract infections
  5.  Urinary incontinence and voiding disorders
  6.  Pediatric urology and congenital disorders
  7.  Genitourinary trauma
  1.  Upgrading of the urodynamics unit.
  2.  Upgrading of the transrectal ultrasonography unit
  3.  Advanced urologic procedures; including all enodurologic and laparoscopic surgeries
  4.  Foundation of renal transplantation team and starting the procedure
  5.  The use of 110 Watt LASER machine (Holmium) for stone treatment, superficial bladder tumors and infravseical obstruction including benign prostate hyperplasia “BPH”
  6.  Extracorporeal Shock Wave Lithotripsy “ESWL”
  7. Flexible uretero-renoscopy

  1.  Transrectal ultrasonography with prostate biopsies
  2.  Urodynamics testing
  3.  Laparoscopic urologic procedures
  4.  Open urologic procedures
  5.  Upper and lower tract endoscopic procedures (diagnostic-therapeutic) including flexible cystoscope
  1.  Daily outpatient clinic : composed of 2 examination rooms (attendance and examination room), which is supervised by a lecturer and attended by assistant lecturer and resident)
  2.  Inpatient sector that includes 40 beds in free sector, 20 beds in private and insurance sectors
  3.  Urodynamics Unit
  4.  Transresctal Ultrasonography Unit
  5. Operating theatres (5 operating tables)
  1.  Lecture rooms for weekly scientific meetings, workshops and seminars in collaboration with other universities and international urological centers
  2.  Animal house for scientific and surgical research in various urological aspects
  3.  Daily case management discussions concerning the inpatient cases and selected outpatient clinic cases
  4.  Weekly discussion of the inpatient cases as well as the pre- and post-operative cases of the inpatient sector
  1.  ESWL
  2.  Laparoscopic surgery
  3.  LASER
  4.  Flexible Ureteroscope
  5.  Electronic archiving system connected to hospital departments including the laboratory and radiology departments

1. Services of Urology Department

a. Outpatient services

    •  Daily outpatient clinic
    •  ESWL unit: The unit includes an electrohydraulic machine that is considered one of the most minimal invasive procedures for stone management, which does not require anesthesia.
    •  Urodynamics unit: the unit offers a full range of urodynamic investigations including urine flowmetry, pressure flow study, Urethral pressure profile (UPP) and Electromyogram (EMG). It is one of the best units in the region, where 400 urodynamics tests are annually performed by a highly expert team with experience in both test performance well as results interpretation.
    •  Transrectal ultrasound (TRUS) unit: TRUS is considered one of the most important tools in the diagnosis of prostate cancer, where an average of 300 cases are annually done including TRUS guided prostate biopsies as well as diagnostic TRUS (for other non-malignant urologic conditions in males).
    •  Flexible cystoscopy

b. Inpatient services

  •  Stone management
      1.  Endo-urology
      2.  Flexible cystoscopy and Flexible ureteroscopy
      3.  Laser and pneumatic lithotripsy
      4.  ESWL
      5.  Conventional surgery
  •  Prostate diseases management
      1.  Benign prostatic enlargement with up to date management including TURP, Bipolar TURP, Holmium laser enucleation of prostate “HOLEP”, Bipolar enucleation of prostate, open prostatectomy and Interventional Radiology (prostatic artery embolization)
      2.  Cancer prostate including early detection, TRUS guided biopsies and Radical prostatectomy
      3.  Uro-oncology including early detection and management of superficial bladder cancer, management of invasive bladder cancer (Radical cystectomy with different types of urinary diversion), upper urothelial carcinoma, prostate cancer, renal cell carcinoma and testicular cancer
      4.  Management of pediatric urological problems and congenital anomalies
      5.  Management of voiding dysfunction problems
      6.  Management of Female urological problems
      7.  Laparoscopic urological surgery

· Internal Projects “Funded by TBRI”

    1.  Lymph node expression of cytokeratin-7 and cytokeratin-20 in extended lymphadenectomy with radical cystectomy for muscle invasive disease: value in pathologic stagement and treatment strategies (2013).
    2.  “Establishment of Specific Operating Procedures (SOP’s) for Human Myoblast Culture. Predictive Tumour and Genetic Markers for Early Diagnosis and Prognosis of Pre-cancerous and Cancerous Bladder Lesion.
    3.  Study of Alterations of Coagulation Balance, Inflammatory Markers and Endothelil Cell Functions by tumour cell Pro-coagulant factors in cancer bladder.
    4.  Comparative study Between Holmium Laser Enucleation of the prostate (HOLEP) and Bipolar Transurethral resection of Prostate in the management of patients with Symptomatic BPH.
    5.  Identification of antimicrobial resistance in normal rectal flora of patients undergoing transrectal ultrasonography guided prostate in Egypt.

· External projects:

Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study (2016-still running)

Publications in the Last Ten Years

Mohamed Wishahi, Hossam Elganzoury, Amr Elkholy, Mohamed H. Badawy, Ahmed S. Zayed, Mohamed A. Ismail, Hani H. Nour, and Samir Eldahshan (2020) : Ultrastructure pattern of smooth muscles of ureteropelvic junction obstruction in adults: an evidence for surveillance rather than pyeloplasty.. Open Access Macedonian Journal of Medical Sciences.

Hani H. Nour, Ahmed I. Kamel, Hazem Elmansy, Mohamad H. Badawy, Waleed Shabana, Ayman Abdelwahab, Ahmed Elbaz, Tarek Eleithy and Mamdouh Rushdy (2020) : Pneumatic vs laser lithotripsy for mid-ureteric stones: Clinical and cost effectiveness results of a prospective trial in a developing country.. Arab J Urol. 10.1080/2090598X.2020.1749800

Enmar Habib, Loay M Ayman, Mohammed Said ElSheemy, Ahmed S El-Feel, Amr Elkhouly, Hany H Nour, Mohamed H Badawy, Ahmad G Elbaz, Mamdouh A Roshdy (2019): Holmium laser enucleation versus bipolar plasmakinetic enucleation of a large volume benign prostatic hyperplasia: a randomised controlled trial. J Endourol.. doi: 10.1089/end.2019.0707.

Ayman Ali, Hany Mostafa, Ahmed Ismail, Mohamed Gamal, Ahmed Salah, Mamdouh Roshdy (2019) : Retrograde intrarenal surgery versus mini percutaneous nephro-lithotripsy to treat renal stones 20 mm or larger in diameter using holmium: YAG laser. Egyptian journal of surgery October 16. DOI: 10.4103/ejs.ejs_120_19.

M Wishahi, MA Ismail, H Elganzoury, A Elkholy, HH Nour, AS Zayed, S Eldahshan (2019) : Genital-Sparing Cystectomy versus Standard Urethral-Sparing Cystectomy Followed with Orthotopic Neobladder in Women with Bladder Cancer: Incidence and Causes of Hypercontinence.. Open Access Maced J Med Sci.;7(6):978-981. doi: 10.3889/oamjms.2019.206.

Amr Hodhod, Fabiola Oquendo, Hani Nour, Ryan Kelly, Walid Shahrour, Ahmed Kotb, Owen Prowse, Hazem Elmansy (2019) :The ex vivo and in vivo Characteristics of New DrillCutTM Prostate Morcellator after Holmium Laser Enucleation of the Prostate: A Pilot Study. Urologia internationalis 103 (1), 95-101. doi: 10.1159/000499092

Hammam O, Magdy M, Badawy M, Osili KA, Kholy AE, LeitHy TE (2017): Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4th Edition Guidelines as a Molecular Insight towards Personalized Medicine. Open Access Maced J Med Sci; 5(5), 578-586.

Hammam O, Aboushousha T, El-Hindawi A, Khairy H, Khalil H, Kamel A, Akl M, Abdel-Hady A, Magdy M, Badawy M, Kholy AE, Osili KA, Kamel N, Anis S, Leithy TE (2017): Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis. Open Access Maced J Med Sci; 5(2), 160-166.

Abdel-Hady A, El-Hindawi A, Hammam O, Khalil H, Diab S, El-Aziz SA, Badawy M, Ismail A, Helmy N, Kamel N, Anis S, Kholy AE, Osili KA, Abdel-Hady A, Nour H, Akl M (2017): Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients. Open Access Maced J Med Sci; 5(2), 147-154.

Abdelhamid MH, Zayed AS, Ghoneima WE, Elmarakbi AA, El Sheemy MS, Aref A, Abdelbary A, Nour HH (2017): Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms. World J Urol; 35(8), 1261-1268.

Raid E, Ghobashy S, Elbaz A, Roshdy M, El Ganzoury H, Kamal A (2015): Retropubic Laparoscopic Prostatectomy: Initial Experience. Life Sci J; 12 (6), 1-5

Kamal AM, Wishahi M, Nour HH, Elganzoury H, Elkhouly A, Salah A, Kamel AI, Elbaz AG, Roushdy M (2015): Ambulant Flexible Cystoscopy for Follow-up of Ta-T1 Urothelial Carcinoma of the Urinary Bladder: Pain Perception and Cost Effective. J Egypt Soc Parasitol; 45(2), 429-433.

Ismail MA, Kamal AM, Ghobashy S, Al Baz AG, Roshdy M (2015): Comparison of pain control during TRUS guided biopsies between basal peri-prostatic local infiltration anesthesia versus combined topical anal lignocaine ointment and local infiltration anesthesia. J Egypt Soc Parasitol; 45(2): 285 -289.

Wishahi M, Elganzoury H, Elkhouly A, Kamal AM, Badawi M, Eseaily K, Kotb S, Morsy M (2015): Computed tomography versus plain radiogram in evaluation of residual stones after percutaneous nephrolithotomy pyelonephrolithotomy for complex multiple and branched kidney stones. J Egypt Soc Parasitol; 45(2): 321-324.

Hammam O, Wishahi M, Khalil H, El Ganzouri H, Badawy M, Elkhouly A, El Esily K (2014): Expression of cytokeratin 7 In urothelial carcinoma and squamous cell carcinoma of the Egyptian urinary bladder cancer. J Egypt Soc Parasitol; 44(3):733-740.

Nour H, Mostafa A, Gobashy G, Elganzoury H, Elkholy A, Riad E (2014): Diagnostic and Prognostic Significance of Serum and Tissue Galactin 3 Expression in Patient with Carcinoma of the Bladder. Curr Urol; 7 (4), 185-190.

Nour HH, Kamal AM, Zayed AS, Refaat H, Badawy MH, El-Leithy TR (2014): Single step renal dilation in percutaneous nephrolithotomy: Prospective Randomized Study. Arab J Urol; 11 (1), 62-67

Lawindi MI, Sayed HA, El Shafei AM, Hayek NN, Noor HH (2014): Assessment of Urinary Tract Infections’ Risk Factors and Knowledge among Attendees of Theodor Bilharz Research Institute, Giza, Egypt: Int Public Health Forum; 1 (1), 25 -29.

Wishahi M, Zakarya A, Hamamm O, Abdel-Rasol M, Badawy H, Elganzoury H, Ismail M, Elkhouly A, Meheina A (2014): Impact of density of schistosomal antigen expression in urinary bladder tissue on the stratification, cell type, and staging, and prognosis of carcinoma of the bladder in Egyptian patients. Infect Agents Cancer; 9, 21.

Zakaria AS, Haddad R, Dragomir A, Kassouf W, Andonian S, Aprikian AG (2014): Royal College surgical objectives of urologic training: A survey of faculty members from Canadian training programs. Can Urol Assoc J; 8: 167-72.

Bishr M, Lattouf JB, Latour M, Saad F (2014): Tumor stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer. Can Urol Assoc J; 8(5-6), E306-10

El Gendy H, Madkour B, Abdelaty S, Essawy F, Khattab D, Hammam O, El Kholy A, Nour HH (2013): Galactin 3 for the diagnosis of bladder cancer. Arab J Urol; 12 (2), 178-181

Shaker O, Hammam O, Wishahi M, Roshdi M. (2013): TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal. Urol Oncol; 31(3), 372-378.

Shaker OG, Hammam OA, Wishahi MM (2013): Is there a correlation between HPV and urinary bladder carcinoma? Biomed Pharmacother; 67, 183-191.

Wishahi MM, Elganzoury H, Elkhouly A, Mehena A. (2013): Dipping technique for ureteroileal anastomosis in orthotopic ileal neobladder: 20-year experience in 670 patients-no stenosis with preservation of the upper tract. ISRN Urol. 26: 725286.

Nour HH, Kamal AM, El Ghobashi S, Zayed AS, Roshdy MM, El-Baz AG, Kamel AI, El-Leithy T (2013): Percutaneous nephrolithotomy in the supine position: Safety and outcomes in a single-center experience. Arab J Urol; 11, 62-67.

Bishr M, Saad F (2013): Overview of the latest treatments for castration-resistant prostate cancer. Nat Rev Urol; 10 (9), 522-528.

Thanan R, Murata M, Ma N, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Oikawa S, Kawanishi S. (2012): Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm; 165879.

Golka K, Abreu-Villaca Y, Anbari Attar R, Angeli-Greaves M, Aslam M, Basaran N, Belik R, Butryee C, Dalpiaz O, Dzhusupov K, Ecke TH, Galambos H, Galambos H, Gerilovica H, Gerullis H, Gonzalez PC, Goossens ME, Gorgishvili-Hermes L, Heyns CF, Hodzic J, Ikoma F, Jichlinski P, Kang BH, Kiesswetter E, Krishnamurthi K, Lehmann ML, Martinova I, Mittal RD, Ravichandran B, Romics I, Roy B, Rungkat-Zakaria F, Rydzynski K, Scutaru C, Shen J, Soufi M, Toguzbaeva K, Vu Duc T, Widera A, Wishahi M, Hengstler JG. (2012): Bladder cancer documentation of causes: multilingual questionnaire, ‘bladder cancer doc’. Front Biosci; 1(4), 2809-2822.

Bishr M, Saad F (2012): Preventing bone complications in prostate cancer. Curr Opin Support Palliat Care; 6(3): 299-303.

Gerullis H, Eimer C, Georgas E, Homburger M, El-Baz AG, Wishahi M, Borós M, Ecke TH and Otto T (2012): Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. Sci World J; 2012:898535.

Elmansy H, Kotb A, Hammam O, Abdelraouf H, Salem H, Onsi M, Elleithy T (2012): Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of Schistosomiasis Ecancermedicalscience; 6:278

Gerullis H, Georgas E, Eimer C, Goretzki PE, Lammers BJ, Klosterhalfen B, Boros M, Wishahi M, Heusch G, Otto T (2011). Evaluation of biocompatibility of alloplastic materials: development of a tissue Culture in iitro test system. Surg Technol Int; 21: 21-7.

Bishr M, Lattouf JB, Gannon PO, Saad F (2011): Updates on therapeutic targets and agents in castration-resistant prostate cancer. Minerva Urol Nefrol; 63(2), 131-143.

Roshdy M, Hammam O, Wishahi M, Nour H (2011): Expression of Transforming Growth Factor Beta-1 Protein and Its Receptor in Tissues of Patients with Bladder Cancer Associated with Schistosomiasis or Not Associated. Curr Urol; 5, 33-40.

Nour H, Abdelrazak O, Wishahy M, Elkatib S, Botto H (2011): Prostate-sparing cystectomy: Potential functional advantages and objective oncological risks; a case series and review. Arab J Urol; 9, 107–112.

Nour H, Mostafa A, Gobashy S, Elganzoury H, Elkholy A, Riad E (2011): Laparoscopic management of primary pelvi-ureteric junction obstruction: Single-centre experience. Arab J Urol; 9, 241–244

Ma N, Thanan R, Kobayashi H, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Amro el-K, Oikawa S, Ohnishi S, Murata M, Kawanishi S (2011): Nitrative DNA damage and OCT3/4 expression in urinary bladder cancer with Schistosoma Hematobium infection. Biochem Biophys Res Commun; 414, 344-349.

Shaker OG, Hammam OA, El Leithy TR, El Ganzoury H, Wishahi MM, Mikhailidis DP (2011): Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal. Clin Biochem; 44(2-3), 237-244

Gerullis H, Ecke T, Eimer C, Wishahi M, Otto T (2011): Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review. Anticancer Drugs; 22(1), 9-17.

Gerullis H, Ecke TH, Wishahi M, Georgas E, Eimer C, Otto T (2010):What happens if nothing happens?–History of an untreated urothelial carcinoma of the bladder. J Egypt Soc Parasitol; 40(3), 789-796.

Kamel MM, Hammam OA, El-Baz AG, El-Baz HG (2010): Potentials of Transforming Growth Factors-Alpha and Beta-1 in Predicting the Clinical Outcome of Bladder Carcinoma. Int J Immun Studies; 2, 169-182

Hammam OA, Abdel Aziz I, Mahmoud O, Zahran M, Alkholy A, Abdel Hadi A, Akl M, Wishahi M, Voss B, Boehm S (2010): Her 2/neu Gene and VEGF in Bladder Cancer in Egypt: Relationship to Schistosomiasis. J Am Sci; 6(12), 927-936

Madkour BS, Bekheit IW, ElBaz AG, Ghobashy H, ElGanzoury H, Essawy FM (2010): Prognostic and predictive significance of haemostatic and angiogenic parameters in cancer bladder patients Journal of American science, 06

Madkour BS, Bekheit IW, Khaled IA, ElBaz AG, Essam FM (2009): Platelet activation: a link between Angiogenesis and Haemostasis in bladder cancer patients. Res J Med Med Sci; 4(2): 212-219

Kamel A, El Baz AG, Abdelsalam WT, Riad MA, Mehena AA (2009): Low dose BCG regimen in T1 transitional cell carcinoma of the bladder: long term results. J Egypt NCI; 21(2), 151-155

Ismail M, Mehena A, Hamam O, ElKhouly A, ElBaz A, Roshdy M (2009): Incidental prostate cancer in patients undergoing cystoprostatectomy for bladder cancer and its clinical implications. Urology; 74(4)

Ismail M, Mehena A, ElLeithy T, ElBaz A, Riad E (2009): Does open surgery has a role in the management of multiple and staghorn kidney stones in the era of minimally invasive surgery. Urology 01, 74(4)

Kamel A, Tosson W, El Baz A, Riad E, Aziz A (2009): Evaluation of low dose BCG in treatment of pT1 Transitional cell carcinoma of the bladder. Long term results. J Egypt NCI; 21(2), 151-155

Shaker OG, Hammam O, Salehd A, el-Leithy T, Wishahi M (2009): Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis. Clin Biochem J; 42, 864-872.

Aziz A, El-Ganzoury H, El-Kholy A, Tosson W, Ismail A, Wishahi M, El-Baz A, Roshdy M, Mahmoud I, El-Leithy T (2008): Continence and Urodynamic parameters: Comparison and long term follow-up of orthotopic Sigmoid and Ileal neobladders . Australian J Basic App Sci; 2(3), 652-657.

El Leithy T, Ismail MA, El-Ghobashy SE, El-Baz AG, Mehena A (2008): Perforating Intravesical Intrauterine Device (IUD), Diagnosis and Treatment. Urotoday ; 1 (5)

El Leithy T (2008): Ureterosigmoidostomy: A Gold Standard in Orthotopic Bladder Era. Res J Med Med Sci; 3 (2), 105-110.

Hammam O, Shaker O., Saleh A, El Leithy T. and Wishahi M (2008): Detection of Telomerase activity using a quantitative assay and immunohistochemistry techniques in common Schistosomal associated bladder lesions. Australian J Basic App Sci; 2(3): 519-526.

El Leithy T, Hammam OA (2008): Expression of TGF-B1 protein and its receptor TGBR-I in tissue of patients with Schistosomal associated bladder cancer. Egypt J Urol; 15(1), 20-26.

El-Ghoubashy S, Swellam T, Abdel-Mohsen M, El Ganzoury H, Ali M, El-Leithy T (2008): Sequential Chemo-Immunotherapy (MMC+BCG) versus single agent immunotherapy (BCG) for recurrent superficial bladder tumors. Arab J Urol; 6 (2), 36-39.

El-Leithy T, Ezzat L (2008): Selective renal embolization: a successful way to control significant bleeding after per-cutaneuos nephrolithotomy (PCNL). Kasr El-Aini Med J; 14 (6), 73-77.

Omar M, Fam N, El-Leithy T, El-Said M, El-Seidi E El-Etreby T (2008): Virulence Factors and Susceptibility Patterns of Candida Species Isolated from Patients with Obstructive Uropathy and Bladder Cancer. Egypt J Med Microbiol; 17 (2), 317-328

Eleithy TR, El-Ghobashy S, Elkholy A, Abdellah T, Ismail MA, El-Kholy A, Roshdy M, Foote J and Bennett J (2008): Augmentation Cystoplasty in neurogenic Bladder Long- Term Urodynamic Evaluations. Arab J Urol; 6 (4), 24-29.

Eleithy TR, El-Ghobashy S, Elkholy A, Abdellah T, Ismail MA, El-Kholy A, Roshdy M, Foote J, Bennett J (2008): Augmentation Cystoplasty in neurogenic Bladder Long- Term Urodynamic Evaluations. Kasr El-Aini Med J; 14 (9), 61-67.

Ismail MA, Elghobashy S, El-Leithy T, El Baz A, Roshdy M, El- Kholi A, El Kalsh T, Mehana A (2008): Open Surgery in the Management of Multiple and staghorn Kidney Stones: Its Role in the Era of Minimally Invasive Techniques. Urotoday; 4.

Riad EM, Roshdy M, Ismail MAA, El-Leithy TR, EL- Ghoubashy S, El Ganzoury H, El Baz AG, Kamel AI (2008): Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) in the eradication of persistent bacteruria associated with infected stones. Australian J Basic App Sci; 2(01), 672-676.

Hammam O, Aziz A, Roshdy M, Abdel-Hadi A (2008): Possible Role of cyclcoxygenase -2 in Schistosomal- Associated Bladder Cancer. Medscape J Med; 10, (3), 60-79.

Book Authorship:

Authors: Tarek Ramzy Elithy , Hazem Elmansy, Olfat Hammam

Title: Prognostic Impact of Apoptosis Markers (Fas & FasL) in Bladder Cancer (2013)

Publisher: LAP LAMBERT Academic Publishing

ISBN-10: 3659342777 – ISBN-13: 978-3659342776